Prab: CSV import

2025-04-06T05:19:00Z

CSV import

← Older revision		Revision as of 05:19, 6 April 2025
Line 1:		Line 1:
			{{SI}}
			{{Infobox medical condition
			\| name = Peripheral T-cell lymphoma not otherwise specified
			\| image = [[File:PTCL-subtypes.jpg\|250px]]
			\| caption = Subtypes of Peripheral T-cell lymphoma
			\| field = [[Hematology]]
			\| symptoms = [[Lymphadenopathy]], [[fever]], [[weight loss]], [[night sweats]]
			\| complications = [[Infection]], [[organ failure]]
			\| onset = Typically in [[adulthood]]
			\| duration = [[Chronic (medicine)\|Chronic]]
			\| types = Various subtypes
			\| causes = Unknown, possibly [[genetic]] and [[environmental factors]]
			\| risks = [[Age]], [[gender]], [[ethnicity]], [[family history]]
			\| diagnosis = [[Biopsy]], [[immunophenotyping]], [[genetic testing]]
			\| differential = Other types of [[lymphoma]], [[reactive lymphoid hyperplasia]]
			\| prevention = None known
			\| treatment = [[Chemotherapy]], [[radiation therapy]], [[stem cell transplant]]
			\| prognosis = Variable, often poor
			\| frequency = Rare
			}}
	'''Peripheral T-cell lymphoma not otherwise specified''' ('''PTCL-NOS''') is a type of [[non-Hodgkin lymphoma]] that affects [[T cells]], which are a type of [[white blood cell]] involved in the [[immune system]]'s response to infection and disease. PTCL-NOS is a catch-all category for peripheral T-cell lymphomas that do not fit into any other specific subtype, making it a heterogeneous group in terms of its presentation, pathology, and prognosis.		'''Peripheral T-cell lymphoma not otherwise specified''' ('''PTCL-NOS''') is a type of [[non-Hodgkin lymphoma]] that affects [[T cells]], which are a type of [[white blood cell]] involved in the [[immune system]]'s response to infection and disease. PTCL-NOS is a catch-all category for peripheral T-cell lymphomas that do not fit into any other specific subtype, making it a heterogeneous group in terms of its presentation, pathology, and prognosis.

	==Epidemiology==		==Epidemiology==
	PTCL-NOS is relatively rare, accounting for about 25-30% of all peripheral T-cell lymphoma cases, which in turn represent a small fraction of all non-Hodgkin lymphomas. It can occur at any age but is more commonly diagnosed in adults, with a median age of presentation in the sixth decade of life. There is a slight male predominance.		PTCL-NOS is relatively rare, accounting for about 25-30% of all peripheral T-cell lymphoma cases, which in turn represent a small fraction of all non-Hodgkin lymphomas. It can occur at any age but is more commonly diagnosed in adults, with a median age of presentation in the sixth decade of life. There is a slight male predominance.

	==Pathophysiology==		==Pathophysiology==
	The exact cause of PTCL-NOS is not well understood, but it is believed to involve genetic mutations that lead to the uncontrolled growth of T cells. These abnormal T cells can accumulate in [[lymph nodes]], the [[spleen]], [[liver]], and other organs, leading to the symptoms associated with the disease.		The exact cause of PTCL-NOS is not well understood, but it is believed to involve genetic mutations that lead to the uncontrolled growth of T cells. These abnormal T cells can accumulate in [[lymph nodes]], the [[spleen]], [[liver]], and other organs, leading to the symptoms associated with the disease.

	==Clinical Features==		==Clinical Features==
	Symptoms of PTCL-NOS can vary widely depending on the organs involved but often include generalized [[lymphadenopathy]] (swollen lymph nodes), [[fever]], [[night sweats]], and [[weight loss]]. Some patients may present with skin lesions, and involvement of the bone marrow can lead to [[anemia]], [[neutropenia]], and [[thrombocytopenia]].		Symptoms of PTCL-NOS can vary widely depending on the organs involved but often include generalized [[lymphadenopathy]] (swollen lymph nodes), [[fever]], [[night sweats]], and [[weight loss]]. Some patients may present with skin lesions, and involvement of the bone marrow can lead to [[anemia]], [[neutropenia]], and [[thrombocytopenia]].

	==Diagnosis==		==Diagnosis==
	Diagnosis of PTCL-NOS requires a biopsy of affected tissue, typically a lymph node. Histopathological examination, along with immunophenotyping and genetic studies, helps distinguish PTCL-NOS from other types of lymphoma and identify its unique characteristics.		Diagnosis of PTCL-NOS requires a biopsy of affected tissue, typically a lymph node. Histopathological examination, along with immunophenotyping and genetic studies, helps distinguish PTCL-NOS from other types of lymphoma and identify its unique characteristics.

	==Treatment==		==Treatment==
	Treatment options for PTCL-NOS are varied and may include [[chemotherapy]], [[radiation therapy]], and in some cases, [[stem cell transplantation]]. The choice of treatment depends on several factors, including the stage and aggressiveness of the disease, as well as the patient's overall health. Novel therapies, including targeted therapies and immunotherapies, are currently under investigation and may offer new hope for patients with this challenging disease.		Treatment options for PTCL-NOS are varied and may include [[chemotherapy]], [[radiation therapy]], and in some cases, [[stem cell transplantation]]. The choice of treatment depends on several factors, including the stage and aggressiveness of the disease, as well as the patient's overall health. Novel therapies, including targeted therapies and immunotherapies, are currently under investigation and may offer new hope for patients with this challenging disease.

	==Prognosis==		==Prognosis==
	The prognosis for patients with PTCL-NOS is generally poor, with a 5-year overall survival rate ranging from 20% to 50%. Factors that can influence prognosis include the stage of the disease at diagnosis, the patient's performance status, and the presence of systemic symptoms.		The prognosis for patients with PTCL-NOS is generally poor, with a 5-year overall survival rate ranging from 20% to 50%. Factors that can influence prognosis include the stage of the disease at diagnosis, the patient's performance status, and the presence of systemic symptoms.

	==Conclusion==		==Conclusion==
	Peripheral T-cell lymphoma not otherwise specified is a complex and challenging disease, both in terms of diagnosis and treatment. Ongoing research into the underlying mechanisms of PTCL-NOS and the development of new therapeutic approaches are essential to improve outcomes for patients with this rare lymphoma.		Peripheral T-cell lymphoma not otherwise specified is a complex and challenging disease, both in terms of diagnosis and treatment. Ongoing research into the underlying mechanisms of PTCL-NOS and the development of new therapeutic approaches are essential to improve outcomes for patients with this rare lymphoma.

	[[Category:Non-Hodgkin lymphoma]]		[[Category:Non-Hodgkin lymphoma]]

	{{medicine-stub}}		{{medicine-stub}}
	~~<gallery>~~
	~~File:PTCL-subtypes.jpg~~
	~~</gallery>~~

Prab: CSV import

2025-02-16T22:14:33Z

CSV import

← Older revision		Revision as of 22:14, 16 February 2025
Line 25:		Line 25:

	{{medicine-stub}}		{{medicine-stub}}
			<gallery>
			File:PTCL-subtypes.jpg
			</gallery>

Prab: CSV import

2024-03-31T14:15:26Z

CSV import

New page

'''Peripheral T-cell lymphoma not otherwise specified''' ('''PTCL-NOS''') is a type of [[non-Hodgkin lymphoma]] that affects [[T cells]], which are a type of [[white blood cell]] involved in the [[immune system]]'s response to infection and disease. PTCL-NOS is a catch-all category for peripheral T-cell lymphomas that do not fit into any other specific subtype, making it a heterogeneous group in terms of its presentation, pathology, and prognosis.

==Epidemiology==
PTCL-NOS is relatively rare, accounting for about 25-30% of all peripheral T-cell lymphoma cases, which in turn represent a small fraction of all non-Hodgkin lymphomas. It can occur at any age but is more commonly diagnosed in adults, with a median age of presentation in the sixth decade of life. There is a slight male predominance.

==Pathophysiology==
The exact cause of PTCL-NOS is not well understood, but it is believed to involve genetic mutations that lead to the uncontrolled growth of T cells. These abnormal T cells can accumulate in [[lymph nodes]], the [[spleen]], [[liver]], and other organs, leading to the symptoms associated with the disease.

==Clinical Features==
Symptoms of PTCL-NOS can vary widely depending on the organs involved but often include generalized [[lymphadenopathy]] (swollen lymph nodes), [[fever]], [[night sweats]], and [[weight loss]]. Some patients may present with skin lesions, and involvement of the bone marrow can lead to [[anemia]], [[neutropenia]], and [[thrombocytopenia]].

==Diagnosis==
Diagnosis of PTCL-NOS requires a biopsy of affected tissue, typically a lymph node. Histopathological examination, along with immunophenotyping and genetic studies, helps distinguish PTCL-NOS from other types of lymphoma and identify its unique characteristics.

==Treatment==
Treatment options for PTCL-NOS are varied and may include [[chemotherapy]], [[radiation therapy]], and in some cases, [[stem cell transplantation]]. The choice of treatment depends on several factors, including the stage and aggressiveness of the disease, as well as the patient's overall health. Novel therapies, including targeted therapies and immunotherapies, are currently under investigation and may offer new hope for patients with this challenging disease.

==Prognosis==
The prognosis for patients with PTCL-NOS is generally poor, with a 5-year overall survival rate ranging from 20% to 50%. Factors that can influence prognosis include the stage of the disease at diagnosis, the patient's performance status, and the presence of systemic symptoms.

==Conclusion==
Peripheral T-cell lymphoma not otherwise specified is a complex and challenging disease, both in terms of diagnosis and treatment. Ongoing research into the underlying mechanisms of PTCL-NOS and the development of new therapeutic approaches are essential to improve outcomes for patients with this rare lymphoma.

[[Category:Non-Hodgkin lymphoma]]

{{medicine-stub}}

Peripheral T-cell lymphoma not otherwise specified - Revision history

Prab: CSV import

Prab: CSV import

Prab: CSV import